Cipla Files ANDA For Advair Rival

FDA Will Now Consider Indian Firm’s Version Alongside Hikma

 
• By David Wallace
Fresh_Air
Cipla’s ANDA is being considered alongside Hikma’s filing • Source: Shutterstock

More from Generics

More from Products